ClinicalTrials.gg
Drug

Empagliflozin clinical trials

Also written Jardiance, BI 10773 and Jardiance 25 MG.

studies test it
404
open now
101
in phase 3
90
first study started
2007
Related medicines add 2 studies

Counted the way a researcher would: Empagliflozin with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses empagliflozin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the empagliflozin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
1 Aug 2014 · JARDIANCE · NDA 204629 (FDA, Drugs@FDA)
European Union
22 May 2014 · Jardiance · EMEA/H/C/002677 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Empagliflozin
141
Empagliflozin 10 MG
81
Empagliflozin 25 MG
39
Empagliflozin (EMPA)
8
Empagliflozin Tablets
7

Brand

Jardiance
89
Jardiance 25 MG
3
Jardiance 10 Mg
2
JARDIANCE 25mg
1

Development codes

BI 10773
37
EMPAA 10mg
1

In one entry with another drug

Given together, or one or the other

Empagliflozin/Metformin
5
Empagliflozin and Metformin
4
Empagliflozin/Linagliptin/Metformin HCl Extended Release Tablet
2
Empagliflozin / Metformin HCl XR Tablets
2
Empagliflozin/Linagliptin/Metformin HCL
2
Empagliflozin + Metformin
2

Studies by the year they started

402 studies that test it; most in 2024 (44); 2 more planned to start later

Studies that test empagliflozin, by start year
YearStudies
20072
20086
200910
201015
201115
20124
20137
20146
20158
201619
201732
201824
201918
202021
202130
202234
202335
202444
202543
202629

By phase

A phase 1/2 study counts in both.

Early Phase 1
9
Phase 1
87
Phase 2
95
Phase 3
90
Phase 4
112
No phase
33

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 129 · Other 275

Boehringer Ingelheim (93) · Humanis Saglık Anonim Sirketi (8) · Tanta University (8) · The University of Texas Health Science Center at San Antonio (8) · University Hospital, Basel, Switzerland (7) · Ain Shams University (6) · The University of Hong Kong (4) · Medanta, The Medicity, India (4)

Often tested with

Tested in the same studies.

Metformin (31) · Dapagliflozin (20) · Linagliptin (20) · Pioglitazone (10) · Semaglutide (9) · Sitagliptin (6) · Finerenone (6) · Canagliflozin (5)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 45, 8 in phase 3

Studies that test empagliflozin, phase 3 first.

Studies

Open first, then newest update. How each study uses empagliflozin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 404

See all 404 studies that test empagliflozin →

Given beside what is tested · 14 — empagliflozin is usual care or a partner of the new treatment
As the comparator · 18 — what is tested is compared with empagliflozin

Codes

What other systems call empagliflozin · ClinicalTrials.gg INT005994

  • MeSH (NLM) C570240empagliflozinConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) HDC1R2M35UEMPAGLIFLOZINConfirmed FDA, NLM, Wikidata
  • RxNorm 1545653Confirmed FDA, Wikidata
  • Wikidata Q5373824empagliflozinConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C158136EmpagliflozinOne source FDA
  • DrugBank DB09038One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.